| Website | cardiodx.com |
| @cardiodx | |
| Category | BioTech |
| Phone | 650-475-2788 |
| info@cardiodx.com | |
| Employees | |
| Founded | 2004 |
| Description | Diagnostics for Coronary heart disease |
| TOTAL | $172M |
| FUNDING TOTAL | $172M |
| Series B, 7/06 Mohr Davidow Ventures Texas Pacific Group Kleiner Perkins Caufield & Byers | $19M |
| Series D, 5/10 Kleiner Perkins Caufield & Byers Mohr Davidow Ventures Intel Capital TPG Growth GE Healthymagination Fund DAG Ventures Pappas Ventures Asset Management Company | $34.5M |
| Venture Round, 5/11 Longitude Capital J.P. Morgan Partners Acadia Woods Partners Artiman Ventures Bright Capital Kleiner Perkins Caufield & Byers Mohr Davidow Ventures TPG Biotech Intel Capital Pappas Ventures DAG Ventures Asset Management Company GE Capital | $60M |
| Venture Round, 8/12 | $58M |
CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failures.
